Research Funding

  • March 15, 2010 - February 29, 2012 - HIV status and reproductive aging affect liver fibrosis in HIV/HCV infected women, Principal Investigator. Sponsor: NIH/NIAID, Sponsor Award ID: R21AI088351
  • October 1, 1974 - March 31, 2009 - GENERAL CLINICAL RESEARCH CENTER, Co-Investigator. Sponsor: NIH, Sponsor Award ID: M01RR000036
  • December 1, 2001 - November 30, 2006 - NRSA Hepatology Training Grant, Co-Principal Investigator. Sponsor: NIH/NIDDK, Sponsor Award ID: T32DK060414
  • December 1, 1974 - September 29, 2006 - General Clinical Research Center, Co-Investigator. Sponsor: NIH/NCRR, Sponsor Award ID: M01RR000079

Education

Melbourne University Medical School, Melbourne, Australia, M.B.B.S., 1972, Medicine
St. Vincent’s Hospital Medical School, Melbourne, Australia, Medicine
Melbourne University, M.D., 1991, Medicine/Immunology

Honors & Awards

  • Honors in Medicine, Pathology, Obstetrics, & Gynecology
  • Burroughs Wellcome Young Investigator in Virology

Selected Publications

  1. Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015.  View on PubMed
  2. Peters MG, Kottilil S, Terrault N, Amara D, Husson J, Huprikar S, Florman S, Sulkowski MS, Durand CM, Luetkemeyer AF, Rogers R, Grab J, Haydel B, Blumberg E, Dove L, Emond J, Olthoff K, Smith C, Fishbein T, Masur H, Stock PG Retrospective-Prospective Study of Safety and Efficacy of Sofosbuvir based Direct Acting Antivirals in HIV/HCV Coinfected Participants with Decompensated Liver Disease Pre or Post Liver Transplant.  View on PubMed
  3. Vergara C, Duggal P, Thio CL, Valencia A, O'Brien TR, Latanich R, Timp W, Johnson EO, Kral AH, Mangia A, Goedert JJ, Piazzola V, Mehta SH, Kirk GD, Peters MG, Donfield SM, Edlin BR, Busch MP, Alexander G, Murphy EL, Kim AY, Lauer GM, Chung RT, Cramp ME, Cox AL, Khakoo SI, Rosen HR, Alric L, Wheelan SJ, Wojcik GL, Thomas DL, Taub MA Correction: Multi-ancestry fine mapping of interferon lambda and the outcome of acute hepatitis C virus infection.  View on PubMed
  4. Vergara C, Valencia A, Thio CL, Goedert JJ, Mangia A, Piazzolla V, Johnson E, Kral AH, O'Brien TR, Mehta SH, Kirk GD, Kim AY, Lauer GM, Chung RT, Cox AL, Peters MG, Khakoo SI, Alric L, Cramp ME, Donfield SM, Edlin BR, Busch MP, Alexander G, Rosen HR, Murphy EL, Wojcik GL, Taub MA, Thomas DL, Duggal P A multi-ancestry sex stratified genome-wide association study of spontaneous clearance of hepatitis C virus.  View on PubMed
  5. Vergara C, Duggal P, Thio CL, Valencia A, O'Brien TR, Latanich R, Timp W, Johnson EO, Kral AH, Mangia A, Goedert JJ, Piazzola V, Mehta SH, Kirk GD, Peters MG, Donfield SM, Edlin BR, Busch MP, Alexander G, Murphy EL, Kim AY, Lauer GM, Chung RT, Cramp ME, Cox AL, Khakoo SI, Rosen HR, Alric L, Wheelan SJ, Wojcik GL, Thomas DL, Taub MA Multi-ancestry fine mapping of interferon lambda and the outcome of acute hepatitis C virus infection.  View on PubMed
  6. Anderson RT, Choi HSJ, Lenz O, Peters MG, Janssen HLA, Mishra P, Donaldson E, Westman G, Buchholz S, Miller V, Hansen BE Association Between Seroclearance of Hepatitis B Surface Antigen and Long-term Clinical Outcomes of Patients With Chronic Hepatitis B Virus Infection: Systematic Review and Meta-analysis.  View on PubMed
  7. Bhattacharya D, Gupta A, Tierney C, Huang S, Peters MG, Chipato T, Martinson F, Mohtashemi N, Dula D, George K, Chaktoura N, Klingman K, Gnanashanmugam D, Currier JS, Fowler MG Hepatotoxicity and Liver-Related Mortality in Women of Child-Bearing Potential Living With HIV and High CD4 Counts Initiating Efavirenz-Containing Regimens.  View on PubMed
  8. Kardashian A, Peters MG, Tien PC, Price JC The Pathogenesis of Liver Disease in People Living With Human Immunodeficiency Virus: The Emerging Role of the Microbiome.  View on PubMed
  9. Nápoles TM, Batchelder AW, Lin A, Moran L, Johnson MO, Shumway M, Luetkemeyer AF, Peters MG, Eagen KV, Riley ED HCV treatment barriers among HIV/HCV co-infected patients in the US: a qualitative study to understand low uptake among marginalized populations in the DAA era.  View on PubMed
  10. Lo Re V, Newcomb CW, Carbonari DM, Roy JA, Althoff KN, Kitahata MM, Reddy KR, Lim JK, Silverberg MJ, Mayor AM, Horberg MA, Cachay ER, Kirk GD, Hull M, Gill J, Sterling TR, Kostman JR, Peters MG, Moore RD, Klein MB, Kim HN Determinants of Liver Complications Among HIV/Hepatitis B Virus-Coinfected Patients.  View on PubMed
  11. Sherman KE, Peters MG, Thomas DL HIV and the liver.  View on PubMed
  12. Naggie S, Fierer DS, Hughes MD, Kim AY, Luetkemeyer A, Vu V, Roa J, Rwema S, Brainard DM, McHutchison JG, Peters MG, Kiser JJ, Marks KM, Chung RT Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals.  View on PubMed
  13. Clarke WT, Miranda J, Neidich E, Hudock R, Peters MG, Kelly EM Metabolic syndrome and liver steatosis occur at lower body mass index in US Asian patients with chronic hepatitis B.  View on PubMed
  14. Sasadeusz J, Grigg A, Hughes PD, Lee Lim S, Lucas M, McColl G, McLachlan SA, Peters MG, Shackel N, Slavin M, Sundararajan V, Thompson A, Doyle J, Rickard J, De Cruz P, Gish RG, Visvanathan K Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Introduction and Immunology.  View on PubMed
  15. Sasadeusz J, Grigg A, Hughes PD, Lim SL, Lucas M, McColl G, McLachlan SA, Peters MG, Shackel N, Slavin M, Sundararajan V, Thompson A, Doyle J, Rickard J, De Cruz P, Gish RG, Visvanathan K Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Patients with Hematological and Solid Tumor Malignancies.  View on PubMed
  16. Sasadeusz J, Grigg A, Hughes PD, Lee Lim S, Lucas M, McColl G, McLachlan SA, Peters MG, Shackel N, Slavin M, Sundararajan V, Thompson A, Doyle J, Rickard J, De Cruz P, Gish RG, Visvanathan K Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Transplant Recipients.  View on PubMed
  17. Sasadeusz J, Grigg A, Hughes PD, Lee Lim S, Lucas M, McColl G, McLachlan SA, Peters MG, Shackel N, Slavin M, Sundararajan V, Thompson A, Doyle J, Rickard J, De Cruz P, Gish RG, Visvanathan K Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Other Populations and Newer Agents.  View on PubMed
  18. Kardashian A, McKinney J, Huynh N, Yu R, Peters M, Catalli L, Price JC Post-sustained Virologic Response Liver Stiffness May Underestimate Fibrosis After Direct Acting Antiviral-containing Therapy.  View on PubMed
  19. Peters MG Long-Term Use of Azathioprine in the Management of Autoimmune Hepatitis.  View on PubMed
  20. Bowlus CL, Yang GX, Liu CH, Johnson CR, Dhaliwal SS, Frank D, Levy C, Peters MG, Vierling JM, Gershwin ME Therapeutic trials of biologics in primary biliary cholangitis: An open label study of abatacept and review of the literature.  View on PubMed

Go to UCSF Profiles, powered by CTSI